M3-Wake Research Acquires Multi-specialty Research Associates (MSRA)
May 18, 2022
M3-Wake Research, part of M3 Inc.'s U.S. research network, has acquired Multi-specialty Research Associates (MSRA) of Lake City, Florida. The acquisition adds an additional site to Wake Research's national footprint, expanding geographic coverage and trial access in Florida.
- Buyers
- M3-Wake Research, M3 Inc.
- Targets
- Multi-specialty Research Associates (MSRA)
- Sellers
- Multi-specialty Research Associates (MSRA), Lauri Adams
- Industry
- Healthcare Services
- Location
- Florida, United States
- Transaction Type
- Addon
Explore More
Related Acquisitions
-
Wake Research Acquires Women's Health Care Research (San Diego)
November 16, 2021
Healthcare Services
Wake Research (M3-Wake Research) has acquired Women's Health Care Research, a San Diego-based clinical trial site led by Dr. Rovena Reagan. The acquisition expands Wake Research's national investigational site network (now five sites in California and 18 sites across seven states) and brings Dr. Reagan into the organization as a Medical Director and Investigator.
-
GeBBS Healthcare Solutions Acquires MRA
October 5, 2023
Healthcare Services
GeBBS Healthcare Solutions, a ChrysCapital portfolio company, has acquired MRA (Medical Record Associates, LLC), a Boston-based provider of HIM, auditing and cancer registry services. The deal expands GeBBS' end-to-end onshore revenue cycle management (RCM) capabilities, US-based delivery footprint and service offering for hospitals, health systems and payers.
-
Avance Clinical Acquires C3 Research Associates to Expand into North America
September 6, 2022
Healthcare Services
Avance Clinical, a PE-backed Australian CRO, has acquired North American CRO partner C3 Research Associates to expand its later‑phase clinical trial capabilities and establish a US presence. Backed by private equity firm The Riverside Company, Avance will integrate C3 into its GlobalReady model and invest in growing its North American team to support biotechs transitioning from early‑phase studies in Australia/New Zealand to later phases in the US.
-
Headlands Research Acquires Trial Management Associates
November 4, 2024
Healthcare Services
Headlands Research has acquired Trial Management Associates (TMA), a multi-site clinical research company with locations in Wilmington, North Carolina and Myrtle Beach, South Carolina. The deal expands Headlands Research's network to 21 sites across the United States and Canada and strengthens its southeastern U.S. footprint and clinical capabilities.
-
The IMA Group Acquires Medical Research Network (MRN) LLC
July 22, 2025
Healthcare Services
The IMA Group has acquired Medical Research Network (MRN) LLC, a New York City–based clinical research site specializing in psychiatry and neurology (CNS) trials. MRN will continue to operate under its current name and leadership (founder and CEO Dr. Michael R. Liebowitz), and the deal expands IMA's CNS footprint with its first East Coast CNS-dedicated location.
-
Ephicacy Consulting Group Acquires Advance Research Associates
May 2, 2024
Healthcare Services
Ephicacy Consulting Group, a biometrics CRO based in Iselin, New Jersey, has acquired Advance Research Associates (ARA), a biostatistics and data management provider based in Santa Clara, California. The add-on expands Ephicacy’s clinical analytics capabilities—particularly in biostatistics and data management—to better serve pharmaceutical, biotechnology, and medical device clients; terms were not disclosed.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.